MAT Waiver Training

PCSS-MAT offers free waiver training for providers to prescribe medication for the treatment of opioid use disorder. Eight hours of training on medication-assisted treatment (MAT) is required to obtain a waiver from the Drug Enforcement Agency to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder.

PCSS-MAT uses two formats in training on MAT. One format is a live eight-hour training and the second is the “half and half” format, which involves 3.75 hours of online training and 4.25 hours of face-to-face training. PCSS-MAT conducts several trainings monthly at no cost throughout the country in an effort to meet the needs of health providers.

(The no-cost training) is a real help to me. It eliminates a barrier in my providing this service for veterans. Thank you very much!

– Waiver Trainee

Trainings are open to all practicing physicians. Residents may take the course and apply for their waiver when they receive their DEA license. Physician Assistants (PAs) and Nurse Practitioners (NPs) are also encouraged to take the course and apply for a waiver pending confirmation of the required 24 hours as defined by Secretary of Health from the Comprehensive Addiction and Recovery Act (CARA) of 2016.

PCSSMAT partner organization, American Osteopathic Academy of Addiction Medicine, provides MAT waiver trainings twice a month that consist of a live training (provided in a webinar format) and an online portion that must be completed after participating in the full live training webinar. View the list of AOAAM trainings.

Healthcare settings and residency training programs may also request a training through the PCSS-MAT program. Residency training programs are often limited to the residents only but will vary by location. If you live in an area where a residency training program is providing a MAT waiver training, contact PCSS-MAT about possibly attending.

NP and PA Information on MAT Waiver Training

NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000-waiver for up to 30 patients may apply by completing the Notification of Intent (NOI) online.

Starting February 27, 2017 SAMHSA will only accept electronic submissions of the NOI. These waiver applications are forwarded to the DEA, which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number.

Visit SAMHSA ›

Notification of Intent

Complete the Notification of Intent Waiver Application online to apply for your waiver to prescribe buprenorphine.

Buprenorphine Waiver Training Advanced Review Module

Online Module with 1 AMA PRA Category 1 credit™

AAAP, in collaboration with PCSS-MAT partners, released this one-hour review course that is FREE of charge and intended for physicians who have already completed the 8-hour required training to obtain their waiver to prescribe buprenorphine but who would like an update.

Then, check out the Buprenorphine Waiver Training Advanced Review MAT CHAT Archive designed to follow the above module.